Cargando…

Clinical Applications of Genomic Alterations in ATLL: Predictive Markers and Therapeutic Targets

SIMPLE SUMMARY: In this review paper, we aim to summarize recent findings of genomic alterations found in adult T-cell leukemia/lymphoma (ATLL), which is an incurable disease induced by a virus; human T-cell leukemia virus type 1 (HTLV-1). Genomic alterations of ATLL have been comprehensively analyz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Noriaki, Miyoshi, Hiroaki, Ohshima, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068906/ https://www.ncbi.nlm.nih.gov/pubmed/33918793 http://dx.doi.org/10.3390/cancers13081801

Ejemplares similares

Clinical significance of CADM1/TSLC1/IgSF4 expression in Adult-T cell leukemia/lymphoma (ATLL): identification of various types of ATLL cells
por: Nakahata, Shingo, et al.
Publicado: (2011)

Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients
por: Rauch, Daniel A., et al.
Publicado: (2011)

CCR4 drives ATLL jail break
por: Shannon, Kevin M.
Publicado: (2014)

Comprehensive genomic analysis identifying heterogeneity in peripheral T‐cell lymphoma
por: Yoshida, Noriaki, et al.
Publicado: (2021)

The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis
por: Moles, Ramona, et al.
Publicado: (2015)

The importance of the clinical classification of adult T-cell leukemia/lymphoma (ATLL) in the prognosis
por: Oliveira, Pedro Dantas, et al.
Publicado: (2022)

HTLV-1, ATLL, severe hypercalcaemia and HIV-1 co-infection: an overview
por: Laher, Abdullah Ebrahim, et al.
Publicado: (2018)

Arsenic trioxyde in the treatment of HTLV1 associated ATLL
por: Suarez, Felipe, et al.
Publicado: (2011)

Neurolymphomatosis in patient with Adult T-cell leukaemia/lymphoma (ATLL)
por: Yoshimitsu, Maki, et al.
Publicado: (2015)

Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL)
por: Xu, Xin, et al.
Publicado: (2020)

MYC translocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B‐cell lymphoma
por: Kawamoto, Keisuke, et al.
Publicado: (2016)

Baseline CD8 T-cell activation is not associated with survival in ATLL
por: Taylor, Graham P, et al.
Publicado: (2015)

Transformer-based personalized attention mechanism for medical images with clinical records
por: Takagi, Yusuke, et al.
Publicado: (2023)

A phase II study of lenalidomide in patients with relapsed or refractory ATLL
por: Phillips, Adrienne A, et al.
Publicado: (2014)

HTLV-1, ATLL, refractory hypercalcaemia and HIV-1 co-infection
por: Laher, Abdullah E, et al.
Publicado: (2018)

Live attenuated VZV vaccination induces antitumor immunity in ATLL patients
por: Jo, Tatsuro, et al.
Publicado: (2022)

Tumor microenvironment of adult T-cell leukemia/lymphoma
por: Takeuchi, Mai, et al.
Publicado: (2021)

Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers
por: Nakahata, Shingo, et al.
Publicado: (2014)

ATLL introduction: is there a standard of care for treatment of adult T cell Leukemia Lymphoma?
por: Bazarbachi, Ali, et al.
Publicado: (2014)

Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α
por: Hodson, Andrew, et al.
Publicado: (2014)

Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function
por: Nagate, Yasuhiro, et al.
Publicado: (2020)

High HTLV-I proviral load in patients with HAM/TSP and ATLL but not with other disorders
por: Altamirano, Natalia, et al.
Publicado: (2011)

Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients
por: Akbarin, Mohammad Mehdi, et al.
Publicado: (2017)

Combined use of pathological and genomic alteration analyses for the diagnosis of gray zone lymphoma
por: Nishimura, Komei, et al.
Publicado: (2022)

Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018)
por: Kawano, Noriaki, et al.
Publicado: (2019)

Cumulative kinetics of epigenetic abnormalities during initiation and progression of Adult T-cell Leukemia/Lymphoma (ATLL)
por: Oka, Takashi, et al.
Publicado: (2011)

Meta-Analysis of HTLV-1-Infected Patients Identifies CD40LG and GBP2 as Markers of ATLL and HAM/TSP Clinical Status: Two Genes Beat as One
por: Fukutani, Eduardo Rocha, et al.
Publicado: (2019)

STX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomas
por: Yoshida, Noriaki, et al.
Publicado: (2015)

HTLV-1 infection of Humanized SCID mice recapitulates Adult T-cell Leukemia/Lymphoma (ATLL) development
por: Banerjee, Prabal, et al.
Publicado: (2009)

A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis
por: Vicario, Mattia, et al.
Publicado: (2018)

Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using machine learning
por: Ghobadi, Mohadeseh Zarei, et al.
Publicado: (2022)

Altered DNA methylation in kidney disease: useful markers and therapeutic targets
por: Hayashi, Kaori
Publicado: (2022)

First line treatment of acute and chronic ATLL with zidovudine (AZT) and interferon alpha (IFN-α): haematological and molecular responses
por: Hodson, Andrew, et al.
Publicado: (2011)

HTLV-1 proviral load in adult T-cell leukemia/lymphoma (ATLL) patients from non-endemic regions of Argentina
por: Mangano, Andrea, et al.
Publicado: (2014)

Guillain-Barré-like Syndrome, as a Rare Presentation of Adult T-cell Leukemia-Lymphoma (ATLL): A Case Report
por: Sasannejad, Payam, et al.
Publicado: (2012)

Degradation of p47 by autophagy contributes to CADM1 overexpression in ATLL cells through the activation of NF-κB
por: Sarkar, Bidhan, et al.
Publicado: (2019)

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL)
por: Zarei-Ghobadi, Mohadeseh, et al.
Publicado: (2021)

Identification of multiple subclones in peripheral T-cell lymphoma, not otherwise specified with genomic aberrations
por: Yoshida, Noriaki, et al.
Publicado: (2012)

Intestinal T-Cell Lymphoma With Lung and Lymph Node Involvement at Relapse
por: Tanaka, Yasuhiro, et al.
Publicado: (2022)

130 Reinhard Kurth Honorary Lecture HTLV-I and Adult T Cell Leukemia/Lymphoma (ATLL): Cellular and Molecular Basis of Transformation
por: Hall, William W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_drgs8hlcmpvmu804boqhcn69n4